Adding Trastuzumab to Standard Chemotherapy in HER2-Positive Esophagogastric Adenocarcinoma: A Further Step Toward Personalized Medicine

ArticleinGastroenterology 140(1):356-8; discussion 358 · November 2010with2 Reads
Impact Factor: 16.72 · DOI: 10.1053/j.gastro.2010.11.011 · Source: PubMed